# Post-Market Bioequivalence (BE) Studies

Canonical: https://abierto.us/opportunities/1303d7fd61d7428e8949ce0ba34b8f5b

- Notice type: Special notice
- Status: Closed. Deadline was November 21, 2025 at 2:20 PM EST
- Department: Department of Health and Human Services
- Agency: Food and Drug Administration
- Contracting office: FDA Office of Acq Grant SVCS (75F401)
- NAICS: 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Product or service code: B529 Scientific Data Studies
- First posted: November 21, 2025
- Last posted: November 21, 2025
- SAM.gov: https://sam.gov/workspace/contract/opp/1303d7fd61d7428e8949ce0ba34b8f5b/view

## Description

This notication serves as a cancellation of a requirement in name FDAFO121683-Post-Market Bioequivalence (BE) Studies

## Publications

- November 21, 2025: Special notice, due November 21, 2025 at 2:20 PM EST. Notice 1303d7fd61d7428e8949ce0ba34b8f5b. https://sam.gov/workspace/contract/opp/1303d7fd61d7428e8949ce0ba34b8f5b/view

## Points of contact

- Telisha Wilson, telisha.wilson@fda.hhs.gov, 2404027572

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/1303d7fd61d7428e8949ce0ba34b8f5b.